Sofos Investments, Inc.
- SEC CIK
- 0001741736
- Latest filing
- May 8, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Sofos Investments, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q1 2026 holdings
- Shares (Q1 2026)
- 51,858
- Value
- $1.91M
- % of portfolio
- 0.3%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 51,858 | $1.91M | 0.3% | +5,838+12.7% | Added | Holders |
| Q4 2025 | 46,020 | $2.34M | 0.5% | +7,132+18.3% | Added | Holders |
| Q3 2025 | 38,888 | $2.16M | 0.4% | – | No prior filing | Holders |
| Q2 2025 | – | – | – | – | Not filed | Holders |
| Q1 2025 | 25,730 | $1.79M | 0.4% | – | No prior filing | Holders |
| Q3 2024 | – | – | – | – | Not filed | Holders |
| Q2 2024 | 23,382 | $3.34M | 0.8% | −23,304−49.9% | Reduced | Holders |
| Q1 2024 | 46,686 | $5.41M | 0.7% | +23,175+98.6% | Added | Holders |
| Q4 2023 | 23,511 | $2.43M | 0.7% | −231,485−90.8% | Reduced | Holders |
| Q3 2023 | 254,996 | – | – | +237,672+1,371.9% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 8,662 | $2.20K | <0.1% | −261−2.9% | Reduced | Holders |
| Q1 2023 | 8,923 | $5.75K | 0.3% | +6,003+205.6% | Added | Holders |
| Q4 2022 | 2,920 | $1.32K | <0.1% | −384−11.6% | Reduced | Holders |
| Q3 2022 | 3,304 | $285.0K | <0.1% | −5,775−63.6% | Reduced | Holders |
| Q2 2022 | 9,079 | $935.0K | 0.1% | +5,427+148.6% | Added | Holders |
| Q1 2022 | 3,652 | $339.0K | <0.1% | −4,104−52.9% | Reduced | Holders |
| Q4 2021 | 7,756 | $680.0K | 0.1% | +1,070+16.0% | Added | Holders |
| Q3 2021 | 6,686 | $731.0K | 0.5% | −8,376−55.6% | Reduced | Holders |
| Q2 2021 | 15,062 | $1.35M | 0.6% | +1,417+10.4% | Added | Holders |
| Q1 2021 | 13,645 | $935 | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.